RMD:ASX
Resmed CDI
A$34.81
arrow_downward
-0.23%(-0.080) 1D
Oct 22, 4:10:29 PM GMT+11 · AUD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RMD...
Open
A$34.83
High
A$34.89
Low
A$34.69
Mkt. cap
34.63B
Avg. vol.
1.11M
Volume
1.54M
52-wk high
A$41.49
52-wk low
A$25.50
Shares outstanding
140.64M
No. of employees
11K
Open
A$34.83
High
A$34.89
Low
A$34.69
Mkt. cap
34.63B
Avg. vol.
1.11M
Volume
1.54M
52-wk high
A$41.49
52-wk low
A$25.50
Shares outstanding
140.64M
No. of employees
11K
News stories
From web sources and news partners
MarketBeat
·
27 minutes ago
ResMed (RMD) Projected to Release Earnings on Thursday
thebull.com.au
·
2 hours ago
ResMed Shares Gaining Steam Ahead of Earnings
Kalkine
·
1 day ago
ResMed Inc. (ASX:RMD): Operations, Earnings and Business Priorities
Simply Wall Street
·
1 day ago
New Mask Launch Could Be A Big Test For ResMed Stock
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees11.4K
FoundedJun 1989
HeadquartersSan Diego, California, United States
SectorMedical device
Websiteresmed.com
Next call in 8 days
Thu, Oct 29, 10:30 PM
Fiscal period
Q1 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.27
Revenue / Est. (USD)
- / 1.39B
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.34B | 1.42B | 1.43B | 1.46B |
Cost of goods sold | 506.94M | 536.28M | 532.58M | 594.13M |
Cost of revenue | 506.94M | 536.28M | 532.58M | 594.13M |
Research and development expenses | 87.32M | 90.97M | 94.27M | 105.72M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 259.19M | 275.70M | 279.80M | 293.36M |
Operating expense | 366.29M | 386.24M | 393.16M | 417.88M |
Total operating expenses | 873.24M | 922.51M | 925.74M | 1.01B |
Operating income | 462.35M | 500.30M | 505.67M | 451.64M |
Other non operating income | -3.84M | 42.00K | 181.00K | 4.40M |
EBT including unusual items | 446.79M | 496.15M | 502.31M | 474.16M |
EBT excluding unusual items | 468.79M | 504.48M | 518.30M | 476.09M |
Income tax expense | 98.26M | 103.56M | 103.58M | 90.73M |
Effective tax rate | 21.99% | 20.87% | 20.62% | 19.14% |
Other operating expenses | - | - | - | - |
Net income | 348.54M | 392.59M | 398.73M | 383.43M |
Net profit margin | 26.10% | 27.59% | 27.86% | 26.20% |
Earnings per share | 2.55 | 2.81 | 0.29 | 0.30 |
Interest and investment income | 4.69M | 4.46M | 3.80M | 31.76M |
Interest expense | - | - | - | - |
Net interest expenses | 4.69M | 4.46M | 3.80M | 31.76M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 503.64M | 543.79M | 558.22M | 490.13M |
Gain or loss from assets sale | - | - | - | - |